We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 306

King v. Burwell: “thy name is an opinion on the Affordable Care Act”
  • Baker & Hostetler LLP
  • USA
  • June 26 2015

The U.S. Supreme Court in King v. Burwell, upheld the availability of subsidies to individuals who purchase health insurance on either a state or


Coats v. Dish Network, LLC: the Colorado Supreme Court provides added certainty regarding a Colorado employee’s use of medical marijuana outside of work
  • Baker & Hostetler LLP
  • USA
  • June 18 2015

On Monday, June 15, 2015, the Colorado Supreme Court, in a long-awaited decision in the Coats v. Dish Network, LLC, case, confirmed what actions


“Ain’t wastin’ time no more” doctors, vets, and lawyers in the antitrust crosshairs
  • Baker & Hostetler LLP
  • USA
  • June 18 2015

Earlier this month a Texas federal district court judge granted a motion by Teladoc, Inc. (Teladoc) for a preliminary injunction enjoining the Texas


Product hopping and antitrust: Mylan court dismisses claims on summary judgment, citing need to avoid chilling pharmaceutical innovation
  • Baker & Hostetler LLP
  • USA
  • May 29 2015

A recent summary judgment opinion from the Eastern District of Pennsylvania breaks new ground in the developing antitrust law on “product hopping”


When a custodian of records has a Fifth Amendment privilege
  • Baker & Hostetler LLP
  • USA
  • May 29 2015

In a recent decision, the U.S. Court of Appeals for the Third Circuit held that a physician acting as custodian of records may not withhold records


Status of pay-for-delay cases nearly two years after Actavis “it ain’t over ’til it’s over.”
  • Baker & Hostetler LLP
  • USA
  • May 18 2015

Nearly two years ago the Supreme Court issued its opinion in FTC v. Actavis, 133 S. Ct. 2223 (2013), holding that a reverse payment made by a brand


Amarin Pharma sues FDA over constitutional right to discuss off-label uses
  • Baker & Hostetler LLP
  • USA
  • May 14 2015

Drug makers and the Food and Drug Administration (FDA) have often disagreed over whether drug makers can discuss unapproved uses for their products


“Ring my friend, I said you call Doctor Robert, day or night he’ll be there”
  • Baker & Hostetler LLP
  • USA
  • May 8 2015

The first lawsuit, in what may be a wave of antitrust litigation challenging professional board regulations in the wake of the U.S. Supreme Court’s


The medical-school-to-prison pipeline continues to widen
  • Baker & Hostetler LLP
  • USA
  • April 23 2015

Physicians now appear to be more than ever at a greater risk of investigation for healthcare crimes, largely due to their "gatekeeping" function


OMB reviewing HRSA proposed rule for civil monetary penalties and ceiling price regulations for 340B Drug Discount Program
  • Baker & Hostetler LLP
  • USA
  • April 20 2015

The agency that oversees the 340B Drug Discount Program (340B program) is seeking review by the White House Office of Management and Budget (OMB) of